October 12, 2020 | 4:58 PM
Pennsylvania treasurer leads calls to lower price of remdesivir
Remdesivir, originally intended as a treatment for Ebola, was developed with $70 million in taxpayer funds.
Remdesivir, originally intended as a treatment for Ebola, was developed with $70 million in taxpayer funds.
In April the National Institutes of Health abruptly terminated funding for the China bat research project with no clear explanation.
Doctors around the country say they still don’t fully understand HHS’s system for distributing the drug.